Restoril and Full blood count decreased - a phase IV clinical study of FDA data

Summary:

Full blood count decreased is reported as a side effect among people who take Restoril (temazepam), especially for people who are male, 60+ old, also take Zyrtec, and have Multiple myeloma.

The phase IV clinical study analyzes which people have Full blood count decreased when taking Restoril. It is created by eHealthMe based on reports of 12,884 people who have side effects when taking Restoril from the FDA, and is updated regularly.

What is Restoril?

Restoril has active ingredients of temazepam. It is often used in insomnia. eHealthMe is studying from 13,522 Restoril users. Check the latest studies of Restoril.

What is Full blood count decreased?

Full blood count decreased is found to be associated with 798 drugs and 703 conditions by eHealthMe. Check the latest studies of Full blood count decreased.

On Jul, 19, 2026

12,884 people reported to have side effects when taking Restoril.
Among them, 21 people (0.16%) have Full blood count decreased.

Could Restoril cause Full blood count decreased?

Among these 21 people:

What is the gender of people who have Full blood count decreased when taking Restoril? *

female: 50 %
male: 50 %

What is the age of people who have Full blood count decreased when taking Restoril? *

What are other drugs people take besides Restoril? *

What are other side effects people have besides Full blood count decreased? *

Haemoglobin Decreased: 7 people, 33.33%
Itching: 4 people, 19.05%
Head Injury: 3 people, 14.29%
Nasal Discomfort: 3 people, 14.29%
Pneumonia: 3 people, 14.29%
Chronic Renal Failure (kidney failure): 3 people, 14.29%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 3 people, 14.29%
Sinusitis (inflammation of sinus): 3 people, 14.29%
Chest Pain: 3 people, 14.29%
Cardiac Valve Disease (heart valve disease): 3 people, 14.29%

What are the existing conditions these people have? *

Primary Myelofibrosis (primary disorder of the bone marrow): 4 people, 19.05%
Multiple Myeloma (cancer of the plasma cells): 4 people, 19.05%
Myelodysplastic Syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged): 3 people, 14.29%
Chest Pain: 3 people, 14.29%
Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 2 people, 9.52%
Stress And Anxiety: 1 person, 4.76%
Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 1 person, 4.76%
Polycythaemia Vera (blood disorder in which the bone marrow makes too many red blood cells): 1 person, 4.76%
Lymphoma (cancer that begins in immune system cells): 1 person, 4.76%
High Blood Pressure: 1 person, 4.76%

* Approximation only. Some reports may have incomplete information.

Do you take Restoril and have Full blood count decreased?

- Check whether Full blood count decreased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Restoril:

Restoril (13,522 reports)

Browse all side effects of Restoril:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Full blood count decreased:

Full blood count decreased (798 drugs)

Browse all the conditions that are associated with Full blood count decreased:

Full blood count decreased (703 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on temazepam (the active ingredients of Restoril) and Restoril (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.